Evaluation of the Xpert MTB/RIF assay for the diagnosis of smear-negative pulmonary and extrapulmonary tuberculosis in Madagascar
Author(s) -
Rivo Andry Rakotoarivelo,
Juan Ambrosioni,
Voahangy Rasolofo,
Mihaja Raberahona,
Niaina Rakotosamimanana,
Radonirina Lazasoa Andrianasolo,
Rado Manitrala Ramanampamonjy,
M. Tiaray Harison,
Joelle Razafimahefa,
J.L. Rakotoson,
Mamy Jean de Dieu Randria,
Françoise Bonnet,
Alexandra Calmy
Publication year - 2018
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2018.01.017
Subject(s) - medicine , extrapulmonary tuberculosis , tuberculosis , human immunodeficiency virus (hiv) , population , cohort , prospective cohort study , diagnostic accuracy , pulmonary tuberculosis , pediatrics , mycobacterium tuberculosis , immunology , pathology , environmental health
To evaluate the feasibility of the implementation of a commercial rapid molecular diagnostic test (Xpert MTB/RIF) for the routine diagnosis of smear-negative or extrapulmonary tuberculosis (TB) and its diagnostic accuracy, and to assess HIV prevalence in a real-life setting in Madagascar. This study was set in a tertiary care hospital in Madagascar.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom